Search

The COVID-19 ‘frontlines’: a foundation doctor’s perspective

Staring through the fragmented stained glass of the Virgin Mary and her assorted angels, I reflected on the strangeness of the workplace I now found myself working in and the irony of a workforce now working together more enthusiastically than...

Embracing assistive technology in the fight against sight loss

The author shares his own experience of sight loss and explains the vital role assistive technology can play in the lives of visually impaired patients. There is no doubt that sight loss continues to be a clear and present danger,...

Designing ophthalmology services Part 3: How do we address the queues post‑COVID-19?

Part 1 of this series available herePart 2 of this series available here There is going to be enormous demand on ophthalmology services as they start to welcome patients back. The authors explain how modelling can help make the most...

Profile of a tertiary referral oculoplastics service in the UK

The provision of safe and effective ophthalmic care to large patient populations has always been challenging. Severe restrictions of outpatient clinical activity due to the COVID-19 crisis has compounded this problem, with 26,800 appointments cancelled in our unit in the...

Could Twitter boost the impact of ophthalmic journal articles?

*Equally contributing co-first authors. The authors investigate the link between ‘tweets’ and citations for 155 articles from five key ophthalmology journals. Social media’s impact on our lives has been significant, allowing easy discussion of topics worldwide. An increasing number of...

Improving cataract efficiency: insights and learnings from expert practitioners

An evening surgical meeting sponsored by Théa Pharmaceuticals Ltd brought together leading experts to share insights and experience on practice strategies to enhance the efficiency of cataract surgery. Streamlining patient flow to optimise capacity and efficiency Qasim Mansoor, Consultant Ophthalmic...

The work of RNIB and ECLOs

With more than 2,000,000 people in the UK living with some degree of sight loss and over 300,000 registered as blind or partially sighted, it is important for anyone living with sight loss to know they’re not alone. At what...

Vision Care for Homeless People

Vison Care for Homeless People (VCHP) was first established in 2003 with the aim to provide eye tests and glasses free of charge to people living in shelters, hostels or who are sleeping rough. Today, we remain the only national...

Pegcetacoplan: A breakthrough treatment for dry age-related macular degeneration?

Age-related macular degeneration (AMD) is a degenerative condition affecting the macula, the part of the retina responsible for central vision. It is characterised by the presence of drusen and retinal pigment epithelium (RPE) abnormalities in the absence of other macular...

In conversation with Robert MacLaren

Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...